Literature DB >> 27630272

Targeting tyrosine receptor kinase B in gliomas.

Kelly V Pinheiro1, Camila Alves1, Marienela Buendia1, Mirela S Gil1, Amanda Thomaz1, Gilberto Schwartsmann1, Caroline Brunetto de Farias1, Rafael Roesler2, Robert L Bowman1, Qianghu Wang1, Angel Carro1, Roel G W Verhaak1, Massimo Squatrito1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27630272      PMCID： PMC5193030          DOI： 10.1093/neuonc/now199

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

Review 1.  Trk receptors: roles in neuronal signal transduction.

Authors:  Eric J Huang; Louis F Reichardt
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

2.  BDNF/TrkB signaling as an anti-tumor target.

Authors:  Rafael Roesler; Caroline Brunetto de Farias; Ana Lucia Abujamra; Algemir Lunardi Brunetto; Gilberto Schwartsmann
Journal:  Expert Rev Anticancer Ther       Date:  2011-10       Impact factor: 4.512

Review 3.  On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.

Authors:  Carol J Thiele; Zhijie Li; Amy E McKee
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

4.  Tyrosine receptor kinase B is a drug target in astrocytomas.

Authors:  Jing Ni; Shaozhen Xie; Shakti H Ramkissoon; Victor Luu; Yu Sun; Pratiti Bandopadhayay; Rameen Beroukhim; Thomas M Roberts; Charles D Stiles; Rosalind A Segal; Keith L Ligon; William C Hahn; Jean J Zhao
Journal:  Neuro Oncol       Date:  2016-07-10       Impact factor: 12.300

5.  Neurotrophin signaling via TrkB and TrkC receptors promotes the growth of brain tumor-initiating cells.

Authors:  Samuel Lawn; Niveditha Krishna; Alexandra Pisklakova; Xiaotao Qu; David A Fenstermacher; Michelle Fournier; Frank D Vrionis; Nam Tran; Jennifer A Chan; Rajappa S Kenchappa; Peter A Forsyth
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

6.  Expression of the neurotrophin receptors Trk A and Trk B in adult human astrocytoma and glioblastoma.

Authors:  Shashi Wadhwa; Tapas C Nag; Anupam Jindal; Rahul Kushwaha; Ashok K Mahapatra; Chitra Sarkar
Journal:  J Biosci       Date:  2003-03       Impact factor: 1.826

7.  BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.

Authors:  Amanda Thomaz; Mariane Jaeger; Marienela Buendia; Victorio Bambini-Junior; Lauro José Gregianin; Algemir Lunardi Brunetto; André T Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

8.  TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells.

Authors:  Sandra Pinet; Barbara Bessette; Nicolas Vedrenne; Aurélie Lacroix; Laurence Richard; Marie-Odile Jauberteau; Serge Battu; Fabrice Lalloué
Journal:  Oncotarget       Date:  2016-08-02

9.  Neurotrophin receptors expression and JNK pathway activation in human astrocytomas.

Authors:  Martha Assimakopoulou; Maria Kondyli; George Gatzounis; Theodore Maraziotis; John Varakis
Journal:  BMC Cancer       Date:  2007-10-31       Impact factor: 4.430

10.  Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.

Authors:  Tiago Elias Heinen; Rafael Pereira Dos Santos; Amanda da Rocha; Michel Pinheiro Dos Santos; Patrícia Luciana da Costa Lopez; Marco Aurélio Silva Filho; Bárbara Kunzler Souza; Luís Fernando da Rosa Rivero; Ricardo Gehrke Becker; Lauro José Gregianin; Algemir Lunardi Brunetto; André Tesainer Brunetto; Caroline Brunetto de Farias; Rafael Roesler
Journal:  Oncotarget       Date:  2016-06-07
  10 in total
  4 in total

Review 1.  BDNF and its signaling in cancer.

Authors:  Mohammad Malekan; Sasan Salehi Nezamabadi; Elham Samami; Mehdi Mohebalizadeh; Amene Saghazadeh; Nima Rezaei
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-29       Impact factor: 4.322

2.  Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma.

Authors:  Kelly V Pinheiro; Amanda Thomaz; Bárbara Kunzler Souza; Victoria Anne Metcalfe; Natália Hogetop Freire; André Tesainer Brunetto; Caroline Brunetto de Farias; Mariane Jaeger; Victorio Bambini; Christopher G S Smith; Lisa Shaw; Rafael Roesler
Journal:  Mol Biol Rep       Date:  2020-08-29       Impact factor: 2.316

Review 3.  Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.

Authors:  Manali Tilak; Jennifer Holborn; Laura A New; Jasmin Lalonde; Nina Jones
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

4.  Clinical Value Screening, Prognostic Significance, and Key Gene Identification of TrkB in Laryngeal Carcinoma.

Authors:  Jing Zhang; Xiaoyan Hu; Shuang Liu; Yuxiao He; Liangge Lyu; Liang Jiang
Journal:  Dis Markers       Date:  2022-08-19       Impact factor: 3.464
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.